| 1 | Amend Articles 25 and 28 of Bylaws To Comply With Legal Changes
| For |
| 2 | Amend Article 16 of Bylaws Re: Length of Term of Representative of Employee Shareholders to the Board
| For |
| 3 | Approve Financial Statements and Statutory Reports
| Abstain |
| 4 | Approve Consolidated Financial Statements and Statutory Reports
| Abstain |
| 5 | Approve Treatment of Losses
| For |
| 6 | Approve Standard Accounting Transfers
| For |
| 7 | Approve Transaction with Deutscher Sparkassen Verlag GmbH (DSV) Re: Business Combination Agreement
| For |
| 8 | Re-Elect Mette Kamsvåg - Non-Executive Director | For |
| 9 | Re-Elect Caroline Parot - Non-Executive Director | Oppose |
| 10 | Re-Elect Georges Pauget - Senior Independent Director | For |
| 11 | Re-Elect Luc Rémont - Non-Executive Director | For |
| 12 | Re-Elect Michael Stollarz - Non-Executive Director | Oppose |
| 13 | Re-Elect Susan M. Tolson - Non-Executive Director | For |
| 14 | Renew Appointment of Johannes Dijsselhof as Censor
| Oppose |
| 15 | Renew Appointment of Deloitte & Associes as Auditor
| Oppose |
| 16 | Acknowledge End of Mandate of BEAS as Alternate Auditor and Decision Not to Replace and Renew
| For |
| 17 | Ratify Change Location of Registered Office to Puteaux 92800, 1 Place des Degres, Tour Voltaire and Amend Article 4 of Bylaws Accordingly.
| For |
| 18 | Approve Compensation Report of Corporate Officers
| Oppose |
| 19 | Approve Compensation of Bernard Bourigeaud, Chairman of the Board
| For |
| 20 | Approve Compensation of Gilles Grapinet, CEO (and Chairman of the Board Until Separation of Functions)
| Oppose |
| 21 | Approve Compensation of Marc-Henri Desportes, Vice-CEO
| Oppose |
| 22 | Approve Remuneration Policy of Chairman of the Board
| For |
| 23 | Approve Remuneration Policy of CEO
| Oppose |
| 24 | Approve Remuneration Policy of Vice-CEO
| Oppose |
| 25 | Approve Remuneration Policy of Directors
| For |
| 26 | Authorise Share Repurchase | Oppose |
| 27 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| 28 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to 50 Percent of Issued Capital
| For |
| 29 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights with a Binding Priority Right up to 10 Percent of Issued Capital
| Oppose |
| 30 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to 10 Percent of Issued Capital
| Oppose |
| 31 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 28 to 30
| Oppose |
| 32 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| For |
| 33 | Authorize Capitalization of Reserves of Up to EUR 500 Million for Bonus Issue or Increase in Par Value
| For |
| 34 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 650,000
| Oppose |
| 35 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| 36 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries
| Oppose |
| 37 | Authorize up to 2 Percent of Issued Capital for Use in Stock Option Plans
| Oppose |
| 38 | Authorize up to 0.7 Percent of Issued Capital for Use in Restricted Stock Plans With Performance Conditions Attached
| Oppose |
| 39 | Authorize Filing of Required Documents/Other Formalities
| For |
